Abcam Founder Launches Grab for Votes to Block $5.7 Billion Deal
Jonathan Milner, the founder of UK life sciences company Abcam Plc, has fired the starting gun on a
2023-09-28 12:47
Corporate America Brings Its New Skinny Look to Stock Market
Wall Street is preparing for a wave of spinoffs as a slew of household-name companies moves to streamline
2023-09-21 17:52
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:21
Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again
Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal
2023-05-19 22:16
Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed
Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that
2023-05-09 02:20